ABSTRACT
Introduction
Esophageal cancer is the eighth most common cancer worldwide. It has received considerable attention in recent years because of the rapid increase of the adenocarcinoma histological subtype in Western countries 1, 2 . The prognosis remains poor and the 5-year survival rate is 10% 3 . Therefore, it is important to understand the pathogenesis and develop strategies to prevent this deadly disease.
The development of esophageal adenocarcinoma follows a metaplasia-dysplasia-carcinoma sequence. Chronic reflux is a risk factor for esophageal metaplasia (Barrett's esophagus) and adenocarcinoma 4, 5 . However, only 10% of individuals with reflux develop Barrett's esophagus (BE), and the estimated lifetime risk for a middle-aged individual with BE to develop adenocarcinoma is 10-15% 6, 7 . Factors other than acid reflux alone might also contribute to the progression from normal epithelia to BE and cancer. In patients with gastroesophageal reflux disease, the concentration of bile acids in the esophageal reflux correlates with the degree of esophageal mucosal injury 8 . Moreover, mixed reflux of gastric and duodenal juices is more common in patients with BE than in normal subjects 8, 9 . The precise mechanisms by which duodenal reflux causes esophageal injury and cancer are unclear, but one of the driving forces may be oxidative stress 10, 11 . Chronic inflammation induced by biological, chemical and physical factors has been associated with increased risk of human cancer at various sites, including the esophagus [12] [13] [14] [15] . One mechanism that may contribute to the development of esophageal cancer is the activation of inflammatory cells that induce and activate several oxidant-generating enzymes. These enzymes produce high concentrations of free radicals and oxidant species. Prolonged exposure to this environment may lead to host cell injury and DNA damage that might initiate tumor formation 16 . Human cells, when exposed to chronic inflammation and oxidative stress, up-regulate anti-oxidant enzymes such as heme oxygenase-1 (HO-1), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). These enzymes may directly mediate inflammatory reaction or contribute to the resolution of inflammation 17, 18 . HO-1 plays a key role in cellular homeostasis as it catalyzes the first and rate-limiting step of heme degradation into equimolar amounts of carbon monoxide (CO), iron and biliverdin, which are subsequently reduced to bilirrubin 19, 20 . HO-1 induction may be an adaptive cellular mechanism in response to oxidative stress. Growth and proliferation of various types of cells seem to be associated with HO-1 expression, and antiapoptotic and pro-angiogenic effects are two possible mechanisms implicated in this process 21, 22 . Therefore, malignant behavior and HO-1 expression may be associated, and an elevated HO-1 activity has been found in cells of renal adenocarcinoma, lymphosarcoma, hepatoma, melanoma and squamous carcinoma [23] [24] [25] [26] . A recent study demonstrated that HO-1 expression is progressively elevated following the sequence from normal oral epithelium to epithelia dysplasia and, finally, to squamous cell cancer in humans 27 . These findings reinforce the idea that oxidative stress may also play an important role in esophageal squamous cell carcinogenesis. HO-1 is expressed in esophageal cancer induced by duodenogastric reflux plus iron supplementation in rats 28 . However, the effect of acid reflux on induction of HO-1 expression in distal esophagus is not well understood.
This study investigated HO-1 expression in distal esophagus in different reflux experimental models 29 . It tested the hypothesis that acid reflux should be accompanied by duodenal juice to induce oxidative damage.
Methods

Tissue samples from experimental model of esophageal carcinogenesis in rats
A total of 100 Wistar rat esophageal specimens embedded in paraffin were available from a previous experimental study conducted in our institution to evaluate histopathological lesions caused by gastric and duodenoesophageal reflux, isolated or in association with diethylnitrosamine (DEN) in an experimental esophageal carcinogenesis model 29 . The rats were divided into five groups of 20 animals each, and a control group was formed with other 10 animals. Groups 1 and 4 comprised esophageal specimens obtained from rats submitted to a cardioplasty to induce gastroesophageal reflux. Gastroesophageal acid reflux was induced by a 6 mm longitudinal incision in all layers of the anterior esophagogastric junction, which was transversally sutured with 7-0 Prolene stitches similar to those used in the Heinecke-Mikulicz pyloroplasty ( Figure 1A ). An esophagoduodenostomy was performed in groups 2 and 5 to induce duodenoesophageal reflux into the distal esophagus. After the release of duodenum and the ligation of gastroesophageal junction, a 1-cm-long lateral esophagoduodenal anastomosis was performed with 6-0 Prolene stitches ( Figure 1B ). Operated animals in group 4 and 5, as well as a group that did not undergo any surgical intervention (Group 6), received a carcinogen, diethylnitrosamine (DEN) obtained from Sigma (St. Louis, MO, USA; N-nitrosodiethylamine, Sigma Chemical 0756) (100 ml flask, density = 0.95g/ml, molecular weight 102.1, chemical formula = C4H10N20). The carcinogen (DEN) was diluted in drinking water and administered to the animals at 5mg/kg/day, considering a daily mean water consumption of 40ml per animal. Group 3 (10 rats) were not exposed to any treatment. This experimental study lasted 22 weeks and originated esophageal specimens embedded in paraffin that were classified into different histological stages in a study published by Melo et al. 29 
Statistical analysis
The Fisher exact and the chi square tests were used for statistical analyses. Statistical significance was set at p<0.05.
Results
C o r re l a t i o n b e t w e e n H O -1 e x p re s s i o n a n d histopathological features
Groups that were not exposed to duodenal contents did not show HO-1 immunoreactivity in the esophagus. Even when Stage II grade lesions were examined, no HO-1 cell expression was observed in groups one, two, four and six (Figures 2 and 3) . In all sections from rats submitted to esophagoduodenal anastomosis (Groups 2 and 5), the results from analysis of mean fluorescence intensity revealed a significant increase of HO-1 expression (4.8 and 4.6 fold, respectively) ( Figure 2 ) when compared with controls (Group 3). These values were similar to mean fluorescence intensity analyzed in tumor slices (5.5 fold) (Figure 2 ). To identify the cells with HO-1 immunoreactivity, the same esophageal area in HE and immunofluorescence labeled slices were examined simultaneously. The comparison of samples revealed that positive HO-1 expression was not uniformly distributed in tissue slices. HO-1 expression was found in inflammatory cells (macrophages, eosinophils and lymphocytes) directly beneath the epithelium or in erosion areas. Squamous cell epithelium did not express HO-1 as observed in adjacent areas with intense inflammatory cells ( Figure 4 ). All HO-1 immunoreactivity was distributed in the distal one-third or two-thirds of the esophagus and no immunoreactivity was found in the upper one-third of the esophagus, not even in the animals with adenocarcinoma. Immunohistochemistry assay for HO-1 expression and quantification HO-1 immunoreactivity was evaluated in a sample containing three different esophageal specimens from each group; the specimens selected had the most severe histopathological changes found in each experimental branch. This sample consisted of three esophageal specimens from group one with papillomatosis and ulceration (Stage II), two with adenocarcinoma (Stage VI) and one with columnar epithelium (Stage III) from group two, three control specimens (Stage I) from group three, three Stage II specimens from group four, three with squamous cell cancer (Stage VI) from group five, and three Stage II specimens from group six.
HO-1 expression was evaluated by immunohistochemistry. Paraffin sections (4 µm) were cut, deparaffinized with xylene and rehydrated. Tissue sections mounted on glass were rehydrated in PBS with 0.1% Triton X-100 for 5 min, washed with PBS and incubated with 2% bovine serum albumin (BSA; Sigma Chem. Co, St. Luis, MO) followed by incubation with polyclonal anti-HO-1 antibody (1:50; Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4o C. Subsequently, tissue slices were washed three times with PBS and incubated with biotin-conjugates anti-rabbit (1:50; Santa Cruz) followed by incubation with streptavidinconjugated FITC (1:50; Caltag Laboratories, Burlingame, CA, USA) for 1 hour at room temperature. Slides were mounted using a solution of 20 mM propyl gallate and 80% glycerol in PBS. Microscopic analysis of images was performed using an epifluorescence microscope (Olympus BX40, Tokyo, Japan) equipped with appropriate filters.
Immunoreactivity to HO-1 was classified by two observers as positive (presence of cellular fluorescence) or negative (unspecific immunolabeling in keratin layer and absence of cellular fluorescence activity). Images were captured using a cooled-charged-coupled device camera (Photometrics, Tucson, AR, USA); the intensity of immune reaction was quantitatively assessed from original images using the Image-Pro Plus 4.0 software In adenocarcinoma tissue slices, HO-1 was expressed in glandular cells and also in tumoral stroma, but the main immunoreactivity was detected in macrophages and other inflammatory cells (eosinophils and lymphocytes) ( Figure 5 ). Severe inflammation and high HO-1 expression in inflammatory infiltrate ( Figure 4) were found also in areas without tumor cells in esophageal tissue from animals exposed to duodenal reflux. However, squamous cell epithelium did not express HO-1 in esophageal tissue with adenocarcinoma. The same profile was observed in tissue with squamous cells carcinoma, where HO-1 expression was intense in inflammatory cells, but not in tumor cells. In addition, when samples from animals exposed to acid reflux were analyzed together (n=6) and samples from those exposed to duodenal juice as another group (n=6), HO-1 expression was significantly different between these two types of reflux models (p<0.05; Table 1 ).
Discussion
Despite advances in the understanding of the association between esophageal adenocarcinoma and gastroesophageal reflux, few studies have investigated their underlying causes. Studies have shown that duodenogastric reflux per se causes intestinal metaplasia and adenocarcinoma in rats, even without exposure to carcinogens 29, 30 . In contrast, gastric contents do not induce this metaplasia-carcinoma sequence 31 . Moreover, esophageal exposure to a mixed type of reflux containing gastric and duodenal juices has been implicated in the development of Barrett's esophagus, and this may explain why some patients do not progress to metaplasia and cancer 8, 9 . Although the precise mechanisms by which reflux of duodenal contents causes esophageal injury and predisposes to neoplasia are not completely understood, there is considerable evidence that chronic inflammation and oxidative damage may play a role in this type of tissue injury 11, 15 . Reactive oxygen species (ROS), superoxide anion (O 2 -), hydrogen peroxide, hydroxyl radicals and nitric oxide (NO) are oxidant molecules constantly generated in vivo and known to be implicated in signaling pathways regulating cell growth and cell redox control. However, they might be produced in excess in chronic inflammatory processes and, thus, exert detrimental effects, such as lipid peroxidation and DNA damage. The progression of oxidative stress damage has been implicated in human cancer 27, 32 . In distal esophagus, Sihvo et al. 15 observed that the reflux diseasemetaplasia-carcinoma sequence revealed progressively increased oxidative stress, which suggested a link between oxidative damage and malignant transformation of esophageal epithelium.
Under physiological conditions, tissues do not express HO-1, an adaptive response to protect cells from oxidative damage. Data suggest that this important cytoprotective effect also occurs in tumor cells because of anti-apoptotic and angiogenic properties 21, 26 . In our study, rats exposed to duodenal reflux developed cancer and expressed HO-1 in a pattern similar to the one found by Chen et al. 28 the less intense glandular cell immunoreactivity seen in our study might be attributed to the fact that we did not offer any iron supplements to the rats. As inflammatory areas with high HO-1 expression were found far from malignant lesions, we agree with other authors that the progression of esophagitis-metaplasia-adenocarcinoma sequence is associated with oxidative stress 15 . However, the histological changes seen in animals exposed to acid reflux were less severe than those in animals exposed to additional duodenal reflux, and it was clear that acid reflux was not sufficient to induce significant oxidative stress in this experimental model. Thus, the difference in HO-1 expression in these two models of reflux might explain why acid reflux did not induce esophageal adenocarcinoma.
Although gastroesophageal reflux disease has not been associated with squamous cell carcinoma of the esophagus 33 , studies with rats have shown that duodenal content reflux into the esophagus induces squamous cell dysplasia and adenocarcinoma in the same way as when a co-carcinogen and a carcinogen are given simultaneously 30, 34, 35 . In addition, chronic thermal injury of the esophagus caused by hot beverage abuse may be involved in esophageal cancer, as demonstrated in an experimental study and a population area 36, 37 . Accordingly, our results suggest that the chronic inflammatory process mediated by duodenal reflux may play a role in the development of squamous cell carcinoma.
Conclusion
Duodenal reflux may act as a co-carcinogen in esophageal squamous cell pathogenesis in rats, which may be mediated by oxidative stress, as suggested by HO-1 expression during histological malignant transformation. Additional studies should focus on oxidative stress, because HO-1 may be a useful biomarker of risk factor for malignant progression.
